vs

Side-by-side financial comparison of Strategy Inc (MSTR) and Schrodinger, Inc. (SDGR). Click either name above to swap in a different company.

Strategy Inc is the larger business by last-quarter revenue ($123.0M vs $87.2M, roughly 1.4× Schrodinger, Inc.). On growth, Strategy Inc posted the faster year-over-year revenue change (1.9% vs -1.2%). Over the past eight quarters, Schrodinger, Inc.'s revenue compounded faster (54.4% CAGR vs 3.3%).

Strategy Inc., formerly known as MicroStrategy, is an American company that provides business intelligence (BI) and mobile software. Founded in 1989 by Michael J. Saylor, Sanju Bansal, and Thomas Spahr, the firm develops software to analyze internal and external data in order to make business decisions and to develop mobile apps. It is a public company headquartered in Tysons Corner, Virginia, in the Washington metropolitan area. Its primary business analytics competitors include SAP SE Busin...

Schrodinger, Inc. is a leading provider of advanced computational chemistry and physics software platforms, along with related consulting services, focused on accelerating drug discovery and novel materials development. Its solutions are adopted by biopharmaceutical companies, chemical manufacturers, academic research institutions and government entities across North America, Europe and Asia Pacific to cut R&D costs and shorten innovation cycles.

MSTR vs SDGR — Head-to-Head

Bigger by revenue
MSTR
MSTR
1.4× larger
MSTR
$123.0M
$87.2M
SDGR
Growing faster (revenue YoY)
MSTR
MSTR
+3.1% gap
MSTR
1.9%
-1.2%
SDGR
Faster 2-yr revenue CAGR
SDGR
SDGR
Annualised
SDGR
54.4%
3.3%
MSTR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSTR
MSTR
SDGR
SDGR
Revenue
$123.0M
$87.2M
Net Profit
$32.5M
Gross Margin
66.1%
65.7%
Operating Margin
-19.7%
Net Margin
37.3%
Revenue YoY
1.9%
-1.2%
Net Profit YoY
180.8%
EPS (diluted)
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSTR
MSTR
SDGR
SDGR
Q4 25
$123.0M
$87.2M
Q3 25
$128.7M
$54.3M
Q2 25
$114.5M
$54.8M
Q1 25
$111.1M
$59.6M
Q4 24
$120.7M
$88.3M
Q3 24
$116.1M
$35.3M
Q2 24
$111.4M
$47.3M
Q1 24
$115.2M
$36.6M
Net Profit
MSTR
MSTR
SDGR
SDGR
Q4 25
$32.5M
Q3 25
$2.8B
$-32.8M
Q2 25
$10.0B
$-43.2M
Q1 25
$-4.2B
$-59.8M
Q4 24
$-670.8M
$-40.2M
Q3 24
$-340.2M
$-38.1M
Q2 24
$-102.6M
$-54.0M
Q1 24
$-53.1M
$-54.7M
Gross Margin
MSTR
MSTR
SDGR
SDGR
Q4 25
66.1%
65.7%
Q3 25
70.5%
51.6%
Q2 25
68.8%
47.8%
Q1 25
69.4%
52.3%
Q4 24
71.7%
72.6%
Q3 24
70.4%
50.2%
Q2 24
72.2%
66.2%
Q1 24
74.0%
51.6%
Operating Margin
MSTR
MSTR
SDGR
SDGR
Q4 25
-19.7%
Q3 25
-84.6%
Q2 25
-96.6%
Q1 25
-5331.4%
-85.5%
Q4 24
-842.1%
-23.5%
Q3 24
-372.7%
-193.9%
Q2 24
-179.7%
-111.4%
Q1 24
-176.8%
-184.3%
Net Margin
MSTR
MSTR
SDGR
SDGR
Q4 25
37.3%
Q3 25
2164.1%
-60.4%
Q2 25
8752.7%
-78.8%
Q1 25
-3797.2%
-100.4%
Q4 24
-555.8%
-45.5%
Q3 24
-293.1%
-108.1%
Q2 24
-92.0%
-114.2%
Q1 24
-46.1%
-149.5%
EPS (diluted)
MSTR
MSTR
SDGR
SDGR
Q4 25
$0.45
Q3 25
$8.42
$-0.45
Q2 25
$32.60
$-0.59
Q1 25
$-16.49
$-0.82
Q4 24
$4.49
$-0.55
Q3 24
$-1.72
$-0.52
Q2 24
$-0.57
$-0.74
Q1 24
$-0.31
$-0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSTR
MSTR
SDGR
SDGR
Cash + ST InvestmentsLiquidity on hand
$2.3B
$395.5M
Total DebtLower is stronger
$8.2B
Stockholders' EquityBook value
$44.1B
$364.1M
Total Assets
$61.6B
$726.2M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSTR
MSTR
SDGR
SDGR
Q4 25
$2.3B
$395.5M
Q3 25
$54.3M
$391.2M
Q2 25
$50.1M
$450.2M
Q1 25
$60.3M
$500.3M
Q4 24
$38.1M
$352.1M
Q3 24
$46.3M
$388.7M
Q2 24
$66.9M
$377.3M
Q1 24
$81.3M
$431.1M
Total Debt
MSTR
MSTR
SDGR
SDGR
Q4 25
$8.2B
Q3 25
$8.2B
Q2 25
$8.2B
Q1 25
$8.1B
Q4 24
$7.2B
Q3 24
$4.2B
Q2 24
$3.8B
Q1 24
$3.6B
Stockholders' Equity
MSTR
MSTR
SDGR
SDGR
Q4 25
$44.1B
$364.1M
Q3 25
$52.3B
$321.4M
Q2 25
$47.5B
$342.9M
Q1 25
$32.2B
$373.5M
Q4 24
$18.2B
$421.4M
Q3 24
$3.8B
$449.4M
Q2 24
$2.8B
$474.0M
Q1 24
$2.4B
$513.7M
Total Assets
MSTR
MSTR
SDGR
SDGR
Q4 25
$61.6B
$726.2M
Q3 25
$73.6B
$653.7M
Q2 25
$64.8B
$688.2M
Q1 25
$43.9B
$743.0M
Q4 24
$25.8B
$823.2M
Q3 24
$8.3B
$669.3M
Q2 24
$7.1B
$688.4M
Q1 24
$6.4B
$737.8M
Debt / Equity
MSTR
MSTR
SDGR
SDGR
Q4 25
0.19×
Q3 25
0.16×
Q2 25
0.17×
Q1 25
0.25×
Q4 24
0.39×
Q3 24
1.12×
Q2 24
1.36×
Q1 24
1.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSTR
MSTR
SDGR
SDGR
Operating Cash FlowLast quarter
$-16.1M
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-18.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSTR
MSTR
SDGR
SDGR
Q4 25
$-16.1M
Q3 25
$-8.3M
$-61.9M
Q2 25
$-34.9M
$-52.2M
Q1 25
$-2.4M
$144.1M
Q4 24
$-17.3M
$-31.1M
Q3 24
$-41.0M
$-33.3M
Q2 24
$-23.3M
$-53.7M
Q1 24
$28.6M
$-39.3M
Free Cash Flow
MSTR
MSTR
SDGR
SDGR
Q4 25
$-16.1M
Q3 25
$-11.1M
$-62.4M
Q2 25
$-37.0M
$-52.5M
Q1 25
$-5.1M
$143.5M
Q4 24
$-17.6M
$-32.0M
Q3 24
$-41.4M
$-34.6M
Q2 24
$-24.1M
$-54.7M
Q1 24
$27.0M
$-43.4M
FCF Margin
MSTR
MSTR
SDGR
SDGR
Q4 25
-18.5%
Q3 25
-8.6%
-114.8%
Q2 25
-32.3%
-95.9%
Q1 25
-4.6%
240.9%
Q4 24
-14.6%
-36.2%
Q3 24
-35.7%
-98.0%
Q2 24
-21.6%
-115.6%
Q1 24
23.5%
-118.5%
Capex Intensity
MSTR
MSTR
SDGR
SDGR
Q4 25
0.0%
Q3 25
2.2%
0.9%
Q2 25
1.8%
0.6%
Q1 25
2.5%
1.0%
Q4 24
0.2%
1.0%
Q3 24
0.4%
3.8%
Q2 24
0.6%
2.1%
Q1 24
1.3%
11.2%
Cash Conversion
MSTR
MSTR
SDGR
SDGR
Q4 25
-0.50×
Q3 25
-0.00×
Q2 25
-0.00×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSTR
MSTR

Segment breakdown not available.

SDGR
SDGR

On Premise Software$44.4M51%
Drug Discovery Services$17.6M20%
Hosted Software$11.5M13%
Maintenance$6.9M8%
Professional Services$3.8M4%
July2024Agreement With Bill Melinda Gates Foundation$2.7M3%

Related Comparisons